Thomas Glenn was named president and chief operating officerof Escagenetics Corp. of San Carlos, Calif. He was vice presidentof pharmaceutical development at Cytel Corp. and president ofBioCryst Inc.
J. Daniel Cole was named executive vice president and chiefoperating officer of Scimed Life Systems Inc. of Minneapolis. Hewas president of the Edwards Critical Care Division of BaxterInternational.
Thomas Wiggans, executive vice president and chief operatingofficer of CytoTherapeutics Inc. of Providence, R.I., was electedcompany president, replacing Seth Rudnick. Rudnick waselected chairman of the board and will continue as chiefexecutive officer. Wiggans will continue as chief operatingofficer and chief financial officer.
Advanced Polymer Systems Inc. of Redwood City, Calif., electedits president and chief executive officer, John Meakem,chairman of the board.
Targeted Genetics Corp. of Seattle named Jon Case director ofcorporate development. He was director, business development,at Centocor Inc.
Protein Design Labs Inc of Mountain View, Calif., named JamesCornett director, business development. Cornett was director,scientific liaison Japan for Centocor Inc.
U.S. Bioscience of West Conshohocken, Pa., named Edith Mitchelldirector of clinical research. She was associate director ofcancer clinical diagnostics at Centocor Inc.
Alza Corp. of Palo Alto, Calif., appointed Gary Neil president andchief executive officer of the newly formed TherapeuticDiscovery Corp., a wholly owned subsidiary of Alza. Neil wasexecutive vice president of American Home Products'subsidiary Wyeth-Ayerst Research.
Stephen Livesey was named chief scientific officer and adirector of LifeCell Corp. of The Woodlands, Texas. Livesy is aco-founder of LifeCell's initial technology and has been ascientific adviser to the company since its founding.
(c) 1997 American Health Consultants. All rights reserved.